Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai.

Modern diet culture often disconnects individuals from their natural hunger signals, promoting meal plans and calorie counting over genuine appetite recognition. This disconnection can lead to ...

and increased hunger and appetite[J]. Annals of internal medicine, 2004, 141(11): 846-850. [3]Willie J T, Chemelli R M, Sinton C M, et al. To eat or to sleep? Orexin in the regulation of feeding and ...

WASHINGTON (Reuters) - U.S. Speaker of the House of Representatives Mike Johnson said on Thursday there is "no appetite" for another funding bill for Ukraine, a day after President Donald Trump ...

Dr Smith highlighted the potential of TheraCryf's Orexin-1 antagonist candidate, which is being developed to address addictive disorders and is approaching a significant phase in its clinical ...

Drugs like Wegovy (semaglutide), Saxenda (liraglutide), and Zepbound (tirzepatide) mimic the peptides in your body to reduce appetite and control cravings. Proteins are made up of smaller units ...

Dr Smith highlighted the potential of TheraCryf's Orexin-1 antagonist candidate, which is being developed to address addictive disorders and is approaching a significant phase in its clinical ...